LATEST TOPICSNEWSMEDICAL UPDATESINTERVIEWSEVENT REPORTSPRODUCTSCRAVITGRACEVITEVENT CALENDARLINKSCONTACT中文 (简体)
  • LATEST TOPICS
  • NEWS
  • MEDICAL UPDATES
  • INTERVIEWS
  • EVENT REPORTS
  • PRODUCTS 
    • CRAVIT
    • GRACEVIT
  • EVENT CALENDAR
  • LINKS
  • CONTACT

Overcoming Challenges in Infectious Diseases

Discover the latest medical research on the prevention, management and treatment of infectious diseases.

LATEST TOPICS

  • To what extent does COVID-19 bacterial co-infection impact clinical outcomes?
    22 May, 2023
    COVID-19, caused by the SARS-CoV-2 virus, has resulted in over 6.8 million deaths worldwide.1 Risk factors associated with severe COVID-19 disease symptoms include advanced age, male sex and...
    Read more

  • Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
    20 April, 2023
    Professor Tang Kejing Deputy Director of Respiratory and Critical Care Medicine and Deputy Director of Infectious Diseases Department, Director of Pharmacy Department, at the First...
    Read more

  • Antiviral, anti-inflammatory, antibacterial... How can patients with COVID-19 be treated?
    19 April, 2023
    Professor Mu Xiangdong Chief Physician, Professor, Mentor to Graduate Students Director, Department of Respiratory and Critical Care, Beijing Tsinghua Chang Gung Memorial Hospital 1st...
    Read more

  • Should we use and how to use anti-bacterial drugs for Covid-19 infection?
    10 April, 2023
    Professor Yang Fan Introduction: Rational use of antimicrobial drugs under viral-bacterial co-infection in the context of the COVID-19 epidemic. With the liberalisation of the COVID-19...
    Read more

CONTENT LIBRARY

NEWS

MEDICAL UPDATES

INTERVIEWS

EVENT REPORTS

CONTENT LIBRARY

News
Medical Updates
Interviews
Event Reports

INTERVIEWS

  • Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
  • Antiviral, anti-inflammatory, antibacterial… How can patients with COVID-19 be treated?
  • Should we use and how to use anti-bacterial drugs for Covid-19 infection?
  • Observing the Development of Quinolones from the Rational Application of Antibacterial Drugs During the COVID-19 Pandemic
  • Combination antibiotic therapy for penicillin non-susceptible Streptococcus pneumoniae
  • Pharmacokinetic and microbial susceptibility studies of sitafloxacin
  • High-Dose Levofloxacin Therapy for Community-onset Enterobacteriaceae Bacteraemia: A New Treatment Paradigm?
  • 60-year development of quinolones: The clinical application of quinolones in urology
  • Standardized treatment of chronic obstructive pulmonary disease (COPD)
  • Standardisation of antimicrobial therapy for bronchiectasis
  • CONTENTS
  • Latest Topics
  • News
  • Medical Updates
  • Interviews
  • Event Reports
  • Products

  • Cravit
  • Gracevit
  • Event Calendar
  • Links
  • Subscribe Email Newsletter
  • ABOUT US
  • Daiichi Sankyo Corporate
  • Contact
  • Terms and Conditions
  • Privacy Policy
  • Sitemap
Copyright© 2023 DAIICHI SANKYO COMPANY, LIMITED. All Rights Reserved.

Disclaimer

Important Notice

The information within this site is intended to provide for Healthcare Professionals (HCP). Please verify that you are a licensed HCP.

Please select the option below that best describes you:

If you’re not an HCP, please visit Daiichi Sankyo’s corporate website.